IBM’s Watson to Guide Cancer Therapies at 14 Centers

Targeting specific genetic changes in cancer cells offers patients personalized therapy for their tumors.  The number of identified abnormalities is rapidly increasing, and determining whether they represent driver mutations or background noise is increasingly difficult.  The IBM Watson supercomputer will be used by 10 US cancer centers to identify actionable targets and match them to existing therapies.